Anita H Clayton Selected Research

bremelanotide

1/2022	Safety Profile of Bremelanotide Across the Clinical Development Program.
1/2022	The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women.
1/2022	Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide.
11/2021	Failure of a Meta-analysis: A Commentary on Glen Spielmans's "Re-Analyzing Phase III Bremelanotide Trials for 'Hypoactive Sexual Desire Disorder in Women'".
11/2019	Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder.
11/2019	Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.
1/2019	Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anita H Clayton Research Topics

Disease

25	Major Depressive Disorder (Major Depressive Disorders) 07/2022 - 11/2002
17	Psychological Sexual Dysfunctions (Sexual Arousal Disorder) 02/2022 - 05/2011
6	Hypotension (Low Blood Pressure) 01/2020 - 10/2017
5	Nausea 01/2022 - 10/2015
5	Syncope (Fainting) 01/2020 - 10/2017
5	Fatigue 01/2019 - 10/2008
4	Headache (Headaches) 01/2022 - 11/2019
4	Sleepiness 12/2019 - 03/2012
4	Schizophrenia (Dementia Praecox) 01/2017 - 06/2007
4	Psychotic Disorders (Schizoaffective Disorder) 09/2015 - 06/2007
3	Body Weight (Weight, Body) 01/2022 - 06/2002
3	Flushing 01/2022 - 11/2019
3	Dizziness (Lightheadedness) 01/2020 - 01/2018
3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2019 - 07/2007
3	Anxiety Disorders (Anxiety Disorder) 10/2016 - 05/2009
2	Neoplasms (Cancer) 12/2021 - 10/2019
2	Autism Spectrum Disorder 11/2019 - 09/2015
2	Psychomotor Agitation (Akathisia) 01/2017 - 07/2014
2	Weight Gain 01/2017 - 03/2012
2	Erectile Dysfunction 01/2016 - 04/2009
2	Mood Disorders (Mood Disorder) 09/2015 - 01/2010
2	Medically Unexplained Symptoms 01/2010 - 07/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Injection Site Reaction 01/2022
1	Hyperpigmentation 01/2022
1	COVID-19 01/2021
1	Vertigo (Positional Vertigo) 01/2020
1	Seizures (Absence Seizure) 11/2019
1	Orthostatic Hypotension (Postural Hypotension) 11/2019
1	Pre-Eclampsia (Preeclampsia) 11/2019
1	Eclampsia 11/2019
1	Symptom Flare Up 01/2018
1	Back Pain (Backache) 01/2018
1	Ejaculatory Dysfunction 01/2016
1	Personality Disorders (Personality Disorder) 01/2014
1	Prescription Drug Misuse 01/2014
1	Chronic Pain 01/2014
1	Pain (Aches) 10/2013
1	Hirsutism 01/2012
1	Acne Vulgaris 01/2012
1	Type 2 Diabetes Mellitus (MODY) 08/2011
1	Amenorrhea 05/2011
1	Breast Neoplasms (Breast Cancer) 05/2011
1	Fever (Fevers) 11/2009

Drug/Important Bio-Agent (IBA)

14	Antidepressive Agents (Antidepressants)IBA 07/2022 - 01/2006
8	flibanserin (BIMT 17)IBA 02/2022 - 10/2017
7	bremelanotideIBA 01/2022 - 01/2019
7	Desvenlafaxine Succinate FDA Link 11/2015 - 04/2009
5	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2018 - 05/2003
4	CytokinesIBA 01/2021 - 08/2008
4	Dopamine (Intropin)FDA LinkGeneric 11/2019 - 04/2009
4	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 03/2007
3	ProlactinIBA 11/2020 - 09/2015
3	Ethanol (Ethyl Alcohol)IBA 01/2020 - 11/2019
3	Vilazodone HydrochlorideIBA 01/2016 - 10/2013
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2014 - 05/2003
3	Bupropion (Wellbutrin)FDA LinkGeneric 07/2014 - 05/2006
3	AntibodiesIBA 08/2011 - 06/2007
2	Melanocortin Receptors (Melanocortin Receptor)IBA 01/2022 - 03/2017
2	Testosterone (Sustanon)FDA Link 01/2022 - 01/2012
2	Antipsychotic Agents (Antipsychotics)IBA 11/2020 - 09/2015
2	brexpiprazoleIBA 11/2020 - 01/2017
2	Pharmaceutical PreparationsIBA 11/2019 - 10/2017
2	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2018 - 12/2015
2	Serotonin and Noradrenaline Reuptake InhibitorsIBA 01/2018 - 07/2014
2	Hormones (Hormone)IBA 03/2017 - 01/2010
2	Aripiprazole (Abilify)FDA Link 01/2017 - 07/2014
2	VortioxetineIBA 10/2016 - 10/2015
2	Escitalopram FDA Link 10/2015 - 05/2006
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 08/2011 - 06/2007
2	EnzymesIBA 12/2010 - 06/2007
2	Biological ProductsIBA 12/2010 - 01/2010
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2010 - 12/2008
2	CalciumIBA 04/2009 - 12/2008
2	Fluoxetine (Prozac)FDA LinkGeneric 05/2003 - 06/2002
1	Hypnotics and Sedatives (Sedatives)IBA 12/2019
1	Tryptamines (Triptans)IBA 01/2019
1	Lurasidone Hydrochloride FDA Link 01/2018
1	Cytochrome P-450 CYP3A InhibitorsIBA 10/2017
1	Melanocyte-Stimulating Hormones (MSH)IBA 03/2017
1	Peptides (Polypeptides)IBA 03/2017
1	ziprasidone (Geodon)FDA Link 01/2017
1	cariprazineIBA 01/2017
1	Citalopram FDA LinkGeneric 07/2015
1	Quetiapine Fumarate (Seroquel)FDA Link 04/2014
1	Opioid Analgesics (Opioids)IBA 01/2014
1	Indicators and Reagents (Reagents)IBA 01/2014
1	Controlled SubstancesIBA 01/2014
1	Prescription DrugsIBA 01/2014
1	BenzodiazepinesIBA 01/2014
1	Protein Isoforms (Isoforms)IBA 08/2011
1	AutoantibodiesIBA 08/2011
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 05/2011
1	Estradiol (Delestrogen)FDA LinkGeneric 05/2011
1	Sertraline (Zoloft)FDA LinkGeneric 05/2009

Therapy/Procedure

5	Therapeutics 01/2020 - 11/2002
4	Drug Therapy (Chemotherapy) 10/2019 - 10/2008
2	Meditation 01/2018 - 12/2015
1	Aftercare (After-Treatment) 12/2021
1	Estrogen Replacement Therapy 01/2010